Back to Search
Start Over
Dramatic effect of early clopidogrel administration in reducing mortality and MACE rates in ACS patients. Data from the Swiss registry AMIS-Plus
- Source :
- Swiss Medical Weekly, vol. 142, pp. w13573
- Publication Year :
- 2012
-
Abstract
- BACKGROUND: Patients who have acute coronary syndromes with or without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy of early clopidogrel administration (300 mg) (
- Subjects :
- Adult
Male
Cardiac Catheterization
Ticlopidine
Time Factors
Myocardial Infarction
610 Medicine & health
2700 General Medicine
Electrocardiography
Young Adult
Confidence Intervals
Odds Ratio
Humans
cardiovascular diseases
Hospital Mortality
Registries
Acute Coronary Syndrome
Aged
Aged, 80 and over
Aspirin
10060 Epidemiology, Biostatistics and Prevention Institute (EBPI)
Middle Aged
Clopidogrel
Logistic Models
Multivariate Analysis
Acute Coronary Syndrome/complications
Acute Coronary Syndrome/drug therapy
Aspirin/therapeutic use
Drug Therapy, Combination
Female
Myocardial Infarction/etiology
Platelet Aggregation Inhibitors/therapeutic use
Switzerland
Ticlopidine/analogs & derivatives
Ticlopidine/therapeutic use
Platelet Aggregation Inhibitors
circulatory and respiratory physiology
Subjects
Details
- Language :
- German
- Database :
- OpenAIRE
- Journal :
- Swiss Medical Weekly, vol. 142, pp. w13573
- Accession number :
- edsair.doi.dedup.....cf09ae6237ad6e2f48ec1fc9a744b5d5